Holocene Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-667,950	Closed	-$68.1M	–	907
2023 Q2	$68.1M	Buy	667,950 +363,225	+119%	+$37M	0.29%	106
2023 Q1	$27.7M	Buy	+304,725	New	+$27.7M	0.14%	174